| Released | Contributor | Author | Title | Pages | Price |
| 26-Dec-2009 | Reuters Investment Profile |
N/A
| PharmAthene Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 23-Dec-2009 | Jefferson Research |
N/A
| Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of PHARMATHENE INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 |
$20 |
| 21-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for PIP | 13 |
$25 |
| 19-Dec-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: PHARMATHENE INC | 5 |
$25 |
| 18-Dec-2009 | Pechala's Reports | Frantisek Pechala | PHARMATHENE INC (PIP=US) 12-months forecast | 1 |
$15 |
| 18-Dec-2009 | Pechala's Reports | Lubomir Pechala | PHARMATHENE INC (PIP=US) 2-weeks forecast | 1 |
$10 |
| 17-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: PHARMATHENE -- PIP | 1 |
$4 |
| 17-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ARYX , DSCO , HEPH , ICGN , MSHL , OGXI , PIP , SOMX -- DRUGS | 3 |
$4 |
| 15-Dec-2009 | Directors Deals Ltd. | Company Snapshot | Company Snapshot - Pharmathene Inc | 1 |
$10 |
| 15-Dec-2009 | EconomicInvestor |
N/A
| "The Economy Matters" Report for PIP: the economy's impact on PIP's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 |
$15 |
0.51% Nasdaq 
Research Reports
